1. Home
  2. CNTB vs FSEA Comparison

CNTB vs FSEA Comparison

Compare CNTB & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • FSEA
  • Stock Information
  • Founded
  • CNTB 2012
  • FSEA 1890
  • Country
  • CNTB United States
  • FSEA United States
  • Employees
  • CNTB N/A
  • FSEA N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • FSEA Savings Institutions
  • Sector
  • CNTB Health Care
  • FSEA Finance
  • Exchange
  • CNTB Nasdaq
  • FSEA Nasdaq
  • Market Cap
  • CNTB 55.2M
  • FSEA 52.1M
  • IPO Year
  • CNTB 2021
  • FSEA N/A
  • Fundamental
  • Price
  • CNTB $0.67
  • FSEA $10.85
  • Analyst Decision
  • CNTB Strong Buy
  • FSEA
  • Analyst Count
  • CNTB 1
  • FSEA 0
  • Target Price
  • CNTB $8.00
  • FSEA N/A
  • AVG Volume (30 Days)
  • CNTB 269.3K
  • FSEA 13.8K
  • Earning Date
  • CNTB 03-31-2025
  • FSEA 05-09-2025
  • Dividend Yield
  • CNTB N/A
  • FSEA N/A
  • EPS Growth
  • CNTB N/A
  • FSEA N/A
  • EPS
  • CNTB N/A
  • FSEA N/A
  • Revenue
  • CNTB $26,033,000.00
  • FSEA $15,874,000.00
  • Revenue This Year
  • CNTB N/A
  • FSEA N/A
  • Revenue Next Year
  • CNTB N/A
  • FSEA N/A
  • P/E Ratio
  • CNTB N/A
  • FSEA N/A
  • Revenue Growth
  • CNTB N/A
  • FSEA 70.41
  • 52 Week Low
  • CNTB $0.51
  • FSEA $8.30
  • 52 Week High
  • CNTB $2.08
  • FSEA $11.69
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 47.33
  • FSEA 44.13
  • Support Level
  • CNTB $0.65
  • FSEA $10.80
  • Resistance Level
  • CNTB $1.00
  • FSEA $11.18
  • Average True Range (ATR)
  • CNTB 0.11
  • FSEA 0.33
  • MACD
  • CNTB 0.02
  • FSEA -0.05
  • Stochastic Oscillator
  • CNTB 38.78
  • FSEA 44.45

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.

Share on Social Networks: